Docencia
Servizo
Publicacións nas que colabora con José Ramón González Juanatey (74)
2023
-
Alpha-cardiac Actin Serum Expression Levels Detect Acute Cellular Rejection in Heart Transplant Patients
Transplantation, Vol. 107, Núm. 2, pp. 466-474
-
Combining Serum miR-144-3p and miR-652-3p as Potential Biomarkers for the Early Diagnosis and Stratification of Acute Cellular Rejection in Heart Transplantation Patients
Transplantation, Vol. 107, Núm. 9, pp. 2064-2072
-
Detection of the Copy Number Variants of Genes in Patients with Familial Cardiac Diseases by Massively Parallel Sequencing
Molecular Diagnosis and Therapy, Vol. 27, Núm. 1, pp. 105-113
-
Role of Soluble ST2 Biomarker in Predicting Recurrence of Atrial Fibrillation after Electrical Cardioversion or Pulmonary Vein Isolation
International Journal of Molecular Sciences, Vol. 24, Núm. 18
-
The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats
Biomedicine and Pharmacotherapy, Vol. 161
2022
-
Diagnostic value of serum miR-144-3p for the detection of acute cellular rejection in heart transplant patients
Journal of Heart and Lung Transplantation, Vol. 41, Núm. 2, pp. 137-147
-
Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases
Journal of Personalized Medicine, Vol. 12, Núm. 7
-
Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers
Scientific Reports, Vol. 12, Núm. 1
-
Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Regulation of Inflammatory Processes in Animal Models
International Journal of Molecular Sciences, Vol. 23, Núm. 10
-
The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile
Frontiers in Pharmacology, Vol. 13
2021
-
Relaxin has beneficial effects on liver lipidome and metabolic enzymes
FASEB Journal, Vol. 35, Núm. 7
2020
-
Adipokines and inflammation: Focus on cardiovascular diseases
International Journal of Molecular Sciences, Vol. 21, Núm. 20, pp. 1-34
-
Inflammatory and lipid regulation by cholinergic activity in epicardial stromal cells from patients who underwent open-heart surgery
Journal of Cellular and Molecular Medicine, Vol. 24, Núm. 18, pp. 10958-10969
-
Polygenic risk score as a key factor in cardiovascular clinical prediction models
Revista Espanola de Cardiologia, Vol. 73, Núm. 8, pp. 608-610
2019
-
A Novel Calsequestrin 2 Deletion Causing Catecholaminergic Polymorphic Ventricular Tachycardia and Sudden Cardiac Death
Revista Espanola de Cardiologia, Vol. 72, Núm. 8, pp. 681-683
-
Circulating Sphingosine-1-Phosphate as A Non-Invasive Biomarker of Heart Transplant Rejection
Scientific reports, Vol. 9, Núm. 1, pp. 13880
-
Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats
Biochemical Pharmacology, Vol. 170
-
Serelaxin (recombinant human relaxin-2) treatment affects the endogenous synthesis of long chain poly-unsaturated fatty acids and induces substantial alterations of lipidome and metabolome profiles in rat cardiac tissue
Pharmacological Research, Vol. 144, pp. 51-65
-
The altered expression of autophagy-related genes participates in heart failure: NRBP2 and CALCOCO2 are associated with left ventricular dysfunction parameters in human dilated cardiomyopathy
PLoS ONE, Vol. 14, Núm. 4
2018
-
ASB1 differential methylation in ischaemic cardiomyopathy: Relationship with left ventricular performance in end-stage heart failure patients
ESC Heart Failure, Vol. 5, Núm. 4, pp. 732-737